Page last updated: 2024-08-23

mifepristone and deoxycytidine

mifepristone has been researched along with deoxycytidine in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Balboa, L; Bruzzo, J; Chiarella, P; Fernández, GC; Isturiz, MA; Laborde, EA; Landoni, VI; Maglioco, A; Rearte, B; Ruggiero, RA	1
Belavic, JM	1

Other Studies

2 other study(ies) available for mifepristone and deoxycytidine

Article	Year
Mifepristone (RU486) restores humoral and T cell-mediated immune response in endotoxin immunosuppressed mice. Clinical and experimental immunology, 2010, Volume: 162, Issue:3 Topics: Animals; Antigens, CD; Cyclophosphamide; Deoxycytidine; Forkhead Transcription Factors; Gemcitabine; Immunity, Cellular; Immunity, Humoral; Immunosuppression Therapy; Immunosuppressive Agents; Lipopolysaccharides; Mice; Mice, Inbred BALB C; Mifepristone; Receptors, Glucocorticoid; T-Lymphocytes; T-Lymphocytes, Regulatory	2010
Drug updates and approvals: 2012 in review. The Nurse practitioner, 2013, Feb-10, Volume: 38, Issue:2 Topics: Acetanilides; Adenine; Antibodies, Monoclonal, Humanized; Benzazepines; Carbamates; Cobicistat; Deoxycytidine; Drug Approval; Drug Combinations; Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Emtricitabine; Fatty Alcohols; Humans; Mifepristone; Nicotinic Acids; Nurse Practitioners; Organophosphonates; Phosphatidylglycerols; Prednisone; Proteins; Pyrimidines; Quinolones; Ranibizumab; Tenofovir; Thiazoles; United States; United States Food and Drug Administration	2013

Article

Year

Mifepristone (RU486) restores humoral and T cell-mediated immune response in endotoxin immunosuppressed mice.

Clinical and experimental immunology, 2010, Volume: 162, Issue:3

Topics: Animals; Antigens, CD; Cyclophosphamide; Deoxycytidine; Forkhead Transcription Factors; Gemcitabine; Immunity, Cellular; Immunity, Humoral; Immunosuppression Therapy; Immunosuppressive Agents; Lipopolysaccharides; Mice; Mice, Inbred BALB C; Mifepristone; Receptors, Glucocorticoid; T-Lymphocytes; T-Lymphocytes, Regulatory

2010

Drug updates and approvals: 2012 in review.

The Nurse practitioner, 2013, Feb-10, Volume: 38, Issue:2

Topics: Acetanilides; Adenine; Antibodies, Monoclonal, Humanized; Benzazepines; Carbamates; Cobicistat; Deoxycytidine; Drug Approval; Drug Combinations; Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Emtricitabine; Fatty Alcohols; Humans; Mifepristone; Nicotinic Acids; Nurse Practitioners; Organophosphonates; Phosphatidylglycerols; Prednisone; Proteins; Pyrimidines; Quinolones; Ranibizumab; Tenofovir; Thiazoles; United States; United States Food and Drug Administration

2013